Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Graft Failure: early-phase trial registry
4 of 6 indexed Graft Failure trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Graft Failure: 6 US clinical trials tracked, 4 recruiting.
Graft Failure is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Baylor Research Institute, running 1 of these trials.
Enrollment posture brief
Registry condition graft-failure
OPEN 4 | RECR 67% | LATE 1 | EARLY 3 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Graft Failure lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Graft Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Graft Failure is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Graft Failure research.
Baylor Research Institute accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Graft Failure trials plan to enrol fewer than 100 people.
Median target enrolment is 58 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Graft Failure research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
Loma Linda University
NCT05084768
Allo HSCT for High Risk Hemoglobinopathies
Masonic Cancer Center, University of Minnesota
NCT06872333
CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure
NYU Langone Health
NCT06569082
Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
Children's Hospital Medical Center, Cincinnati
NCT07244419
Tumescence in HNC Skin Graft Reconstruction
University of California, Davis
NCT04967391
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
Baylor Research Institute
NCT03373227
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Graft Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Graft Failure trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Graft Failure page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Graft Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Baylor Research Institute sponsors the most Graft Failure trials on record, review their full trial history before evaluating a specific study. See Baylor Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Graft Failure condition card totals 6 registered trials; most-linked intervention Envarsus; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.